These novel therapies , Tirzepatide , represent a groundbreaking advancement in managing metabolic dysfunction and possibly other conditions . They all are classified as GLP-1 pathway agonists , https://lilygnfv924869.pages10.com/semaglutide-a-comprehensive-exploration-into-metabolic-copyright-76786450